The DNA foundation model Evo 2 has been published in the journal Nature. Trained on the DNA of over 100,000 species across ...
The company has spent more than a decade developing a non-viral vaccine platform for animal health. According to CEO and cofounder Tom Tillett, MBF is exploring whether its detailed immune-response ...